These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28434297)

  • 21. C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.
    Panayiotou E; Fella E; Papacharalambous R; Malas S; Saraiva MJ; Kyriakides T
    PLoS One; 2017; 12(4):e0175767. PubMed ID: 28407005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular manifestations in hereditary transthyretin Gly67Glu amyloidosis.
    Leung KCP; Ko TCS
    Amyloid; 2019 Sep; 26(3):171-172. PubMed ID: 31135236
    [No Abstract]   [Full Text] [Related]  

  • 23. Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?
    Saponaro F; Kim JH; Chiellini G
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells.
    Nunes RJ; de Oliveira P; Lages A; Becker JD; Marcelino P; Barroso E; Perdigoto R; Kelly JW; Quintas A; Santos SC
    J Biol Chem; 2013 Nov; 288(44):31752-60. PubMed ID: 24030829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial cells in familial amyloidotic polyneuropathy.
    Gonçalves NP; Costelha S; Saraiva MJ
    Acta Neuropathol Commun; 2014 Dec; 2():177. PubMed ID: 25519307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin amyloidosis: a little history of hereditary amyloidosis.
    Benson MD
    Amyloid; 2017 Mar; 24(sup1):76-77. PubMed ID: 28434305
    [No Abstract]   [Full Text] [Related]  

  • 28. Disease-Modifying Treatments for Transthyretin Amyloidosis.
    Tushak ZJ; Cox SZ; Cei LF; Gwathmey KG; Shah KB
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e641-e647. PubMed ID: 34321398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
    Moreira J; Costelha S; Saraiva M; Saraiva MJ
    Front Immunol; 2021; 12():650269. PubMed ID: 34093538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
    Ueda M; Ando Y; Hakamata Y; Nakamura M; Yamashita T; Obayashi K; Himeno S; Inoue S; Sato Y; Kaneko T; Takamune N; Misumi S; Shoji S; Uchino M; Kobayashi E
    Biochem Biophys Res Commun; 2007 Jan; 352(2):299-304. PubMed ID: 17126291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.
    Niemietz C; Chandhok G; Schmidt H
    Molecules; 2015 Sep; 20(10):17944-75. PubMed ID: 26437390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthyretin amyloidosis and the kidney.
    Lobato L; Rocha A
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1337-46. PubMed ID: 22537653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
    Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
    Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Onodera R; Arima H
    Biol Pharm Bull; 2019; 42(10):1679-1688. PubMed ID: 31582656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis and therapy for transthyretin related amyloidosis].
    Ando Y; Jono H
    Rinsho Byori; 2008 Feb; 56(2):114-20. PubMed ID: 18402051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
    Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.
    Ohta M; Sugano A; Hatano N; Sato H; Shimada H; Niwa H; Sakaeda T; Tei H; Sakaki Y; Yamamura KI; Takaoka Y
    Transgenic Res; 2018 Feb; 27(1):15-23. PubMed ID: 29288430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel transgenic mouse model expressing mutant TTR gene causing oculoleptomeningeal type of ATTRm amyloidosis.
    Isoguchi A; Ueda M; Kanenawa K; Masuda T; Misumi Y; Yamashita T; Obayashi K; Ando Y
    Amyloid; 2019; 26(sup1):69. PubMed ID: 31343295
    [No Abstract]   [Full Text] [Related]  

  • 40. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy.
    Ohmori H; Ando Y; Makita Y; Onouchi Y; Nakajima T; Saraiva MJ; Terazaki H; Suhr O; Sobue G; Nakamura M; Yamaizumi M; Munar-Ques M; Inoue I; Uchino M; Hata A
    J Med Genet; 2004 Apr; 41(4):e51. PubMed ID: 15060127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.